Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model
J. Clin. Invest. Christene A. Huang, et al. 105:173 doi:10.1172/JCI7913 [Go to this article.]

Figure 4
Percent of donor PAA⁺ cells detected in the PB after (a) BMT and (b) PBSCT in miniature swine treated with the nonmyeloablative preparative regimen.